Atlas Trials

Prevalence of Gastroesophageal Reflux Disease (GERD) in Patients With Upper Gastrointestinal Tract Symptoms in Egypt

Clinical trial NCT01635959 · COMPLETED

Trial details

NCT number
NCT01635959
Sponsor
AstraZeneca
Status
COMPLETED
Study type
OBSERVATIONAL
Patients With Upper Gastro-intestinal Symptoms
Start date
2012-07-01
Primary completion
2014-07-01
Enrollment
3170

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.